Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Automated Hematology Analyser Market: By Product, By End Users, and Region
Automated Hematology Analyser Market: By Product, By End Users, and Region
Automated Hematology Analyser Market size was US$ 467.3 million in 2023 and is expected to reach US$ 811.3 billion in 2030, growing at a CAGR of 8.2% during the forecast period. Automated hematology analysers are sophisticated medical devices that perform complete blood count (CBC) tests and other related analyses quickly and accurately. They offer high-throughput capabilities, improved precision, and reduced manual intervention in blood sample analysis. The market is experiencing growth due to factors such as the increasing prevalence of blood disorders, rising demand for point-of-care testing, technological advancements in hematology analysers, and growing healthcare expenditure globally.
According to the World Health Organization, anemia affects about 1.62 billion people worldwide, highlighting the need for efficient blood analysis tools. However, the market faced temporary setbacks during the COVID-19 pandemic, with disruptions in supply chains and reduced routine blood testing. The high cost of advanced automated hematology analysers could also impede market growth in some regions, particularly in developing countries.
Study Period
2024-2030Base Year
2023CAGR
8.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The automated hematology analyser market is driven by the increasing need for rapid and accurate blood analysis in various healthcare settings. These analysers play a crucial role in diagnosing and monitoring a wide range of conditions, from anemia to leukemia. The growing prevalence of chronic diseases and the aging population contribute to the rising demand for hematology testing. Technological advancements, such as the integration of artificial intelligence and machine learning algorithms, are enhancing the capabilities of these analysers, allowing for more sophisticated blood cell classification and anomaly detection. The trend towards laboratory automation and the need for standardized, high-quality results are also fueling market growth. In developing countries, the expansion of healthcare infrastructure and increasing awareness about preventive healthcare are creating new opportunities for market expansion.
Based on regions the automated hematology analyser market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the automated hematology analyser market, accounting for the largest share of the global market. This is primarily due to the well-established healthcare infrastructure, high adoption rate of advanced medical technologies, and significant healthcare spending in countries like the United States and Canada. Europe holds a significant market share, driven by the presence of major market players, strong research and development activities, and favorable reimbursement policies. The Asia-Pacific region is projected to experience the fastest growth during the forecast period. This growth is attributed to the rapidly improving healthcare infrastructure, increasing healthcare expenditure, and rising awareness about early disease diagnosis in countries like China and India.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 467.3 million |
|
Market Size in 2030 |
US$ 811.3 billion |
|
Market CAGR |
8.2% |
|
By Product |
|
|
By End User |
|
Download Free Sample Report
The global automated hematology analyser market size was valued at US$ 467.3 million in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030
North America accounts for the highest rate of growth in the automated hematology analyser market.
The major players in the automated hematology analyser market include Sysmex Corporation, Beckman Coulter, Inc. (Danaher Corporation), Abbott Laboratories, Siemens Healthineers, and Horiba, Ltd., among others.
Key drivers include the increasing prevalence of blood disorders, rising demand for point-of-care testing, technological advancements in hematology analysers, and growing healthcare expenditure globally.
Restraints include high initial investment costs, maintenance requirements, and the need for skilled operators. Additionally, in some regions, limited healthcare budgets and lack of awareness about advanced diagnostic technologies can hinder market growth.
| 1.Executive Summary |
| 2.Global Automated Hematology Analyser Market Introduction |
| 2.1.Global Automated Hematology Analyser Market - Taxonomy |
| 2.2.Global Automated Hematology Analyser Market - Definitions |
| 2.2.1.Product |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Automated Hematology Analyser Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Automated Hematology Analyser Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Automated Hematology Analyser Market By Product , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Instruments |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Reagents |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Automated Hematology Analyser Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Clinical Laboratories |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Diagnostics |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Research Institutes |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Automated Hematology Analyser Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Automated Hematology Analyser Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Instruments |
| 8.1.2.Reagents |
| 8.1.3.Others |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Clinical Laboratories |
| 8.2.3.Diagnostics |
| 8.2.4.Research Institutes |
| 8.2.5.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Automated Hematology Analyser Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Instruments |
| 9.1.2.Reagents |
| 9.1.3.Others |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Clinical Laboratories |
| 9.2.3.Diagnostics |
| 9.2.4.Research Institutes |
| 9.2.5.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Automated Hematology Analyser Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Instruments |
| 10.1.2.Reagents |
| 10.1.3.Others |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Clinical Laboratories |
| 10.2.3.Diagnostics |
| 10.2.4.Research Institutes |
| 10.2.5.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Automated Hematology Analyser Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Instruments |
| 11.1.2.Reagents |
| 11.1.3.Others |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Clinical Laboratories |
| 11.2.3.Diagnostics |
| 11.2.4.Research Institutes |
| 11.2.5.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Automated Hematology Analyser Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Instruments |
| 12.1.2.Reagents |
| 12.1.3.Others |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Clinical Laboratories |
| 12.2.3.Diagnostics |
| 12.2.4.Research Institutes |
| 12.2.5.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Sysmex Corporation |
| 13.2.2.Beckman Coulter, Inc. (Danaher Corporation) |
| 13.2.3.Abbott Laboratories |
| 13.2.4.Siemens Healthineers |
| 13.2.5.Horiba, Ltd. |
| 13.2.6.Bio-Rad Laboratories, Inc. |
| 13.2.7.Mindray Medical International Limited |
| 13.2.8.Boule Diagnostics AB |
| 13.2.9.Nihon Kohden Corporation |
| 13.2.10.EKF Diagnostics Holdings plc |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.